Successful implantation of intravenously administered stem cells correlates with severity of inflammation in murine myocarditis

Pflügers Archiv - Tập 452 - Trang 268-275 - 2006
Sohail Malek1, Emel Kaplan1, Ju-Feng Wang1, Qingen Ke1, Jamal S. Rana1, Yu Chen1, Bilal G. Rahim1, Ma Li1, Qin Huang1, Yong-Fu Xiao1, Freek W. A. Verheugt2, James P. Morgan1,3,4, Jiang-Yong Min1,3,4
1Charles A. Dana Research Institute and the Harvard-Thorndike Laboratories of Beth Israel Deaconess Medical Center, The Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, USA
2Department of Cardiology, University Medical Centre Nijmegen, Nijmegen, the Netherlands
3Division of Cardiovascular Medicine, Department of Medicine, Caritas St. Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, USA
4Cardiovascular Center, Caritas Healthcare System, Boston, USA

Tóm tắt

The present study was designed to determine whether cardiac inflammation is important for the successful homing of stem cells to the heart after intravenous injection in a murine myocarditis model. Male Bagg albino/c mice were infected with encephalomyocarditis virus (EMCV) to produce myocarditis. Subgroups of mice received single injections by tail vein of embryonic stem cells (ESCs) transfected with green fluorescent protein (GFP) as a marker at days 3, 14, or 60 after infection; other subgroups without stem cell injections were killed at each of these time points to assess the degree of inflammation present. The surviving mice were killed at day 90 after virus infection and hemodynamics, gross pathology, histology, and inflammatory cytokine production in the hearts were measured. Our results indicate that myocardial inflammation was most severe and cytokine production highest at day 14 after EMCV inoculation, and in particular, was strongly positive for interleukin 6. Mice receiving intravenous ESC injections on day 14 after EMCV inoculation showed the largest number of GFP-positive cells at the time of death and the greatest functional improvement compared to uninfected controls without inflammation. We conclude that factors released from myocardium during inflammation are important for enhancing the homing, migration, and implantation of systemically infused stem cells.

Tài liệu tham khảo

Abbott JD, Giordano FJ (2003) Stem cells and cardiovascular disease. J Nucl Cardiol 10:403–412 Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ (2004) Stromal cell-derived factor 1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110(21):3300–3305 Bahra P, Rainger GE, Wautier JL, Nguyet-Thin L, Nash GB (1998) Each step during transendothelial migration of flowing neutrophils is regulated by the stimulatory concentration of tumour necrosis factor-alpha. Cell Adhes Commun 6:491–501 Chen Y, Ke Q, Yang Y, Rana JS, Tang J, Morgan JP, Xiao YF (2003) Cardiomyocytes overexpressing TNF-alpha attract migration of embryonic stem cells via activation of p38 and c-Jun amino-terminal kinase. FASEB J 17(15):2231–2239 Fabbri M, Bianchi E, Fumagalli L, Pardi R (1999) Regulation of lymphocyte traffic by adhesion molecules. Inflamm Res 48(5):239–246 Halawa B, Salomon P, Jolda-Mydlowska B, Zysko D (1999) Levels of tumor necrosis factor (TNF-alpha) and interleukin 6 (IL-6) in serum of patients with acute myocardial infarction. Pol Arch Med Wewn 101:197–203 Hardy CL (1995) The homing of hematopoietic stem cells to the bone marrow. Am J Med Sci 309(5):260–266 Hardy CL, Tavassoli M (1988) Homing of hemopoietic stem cells to hemopoietic stroma. Adv Exp Med Biol 241:129–133 Hendrikx PJ, Martens CM, Hagenbeek A, Keij JF, Visser JW (1996) Homing of fluorescently labeled murine hematopoietic stem cells. Exp Hematol 24(2):129–140 Hescheler J, Fleischmann BK, Lentini S, Maltsev VA, Rohwedel J, Wobus AM, Addicks K (1997) Embryonic stem cells: a model to study structural and functional properties in cardiomyogenesis. Cardiovasc Res 36:149–162 Ino T, Kishiro M, Okubo M, Akimoto K, Nishimoto K, Yabuta K, Okada R (1997) Late persistent expressions of ICAM-1 and VCAM-1 on myocardial tissue in children with lymphocytic myocarditis. Cardiovasc Res 34(2):323–328 Jacobs M, Staufenberger S, Gergs U, Meuter K, Brandstatter K, Hafner M, Ertl G, Schorb W (1999) Tumor necrosis factor-alpha at acute myocardial infarction in rats and effects on cardiac fibroblasts. J Mol Cell Cardiol 31:1949–1959 Jovinge S, Hultgardh-Nilsson A, Regnstrom J, Nilsson J (1997) Tumor necrosis factor-alpha activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta. Arterioscler Thromb Vasc Biol 17:490–497 Kollet O, Spiegel A, Peled A, Petit I, Byk T, Hershkoviz R, Guetta E, Barkai G, Nagler A, Lapidot T (2001) Rapid and efficient homing of human CD34(+)(−/low)CXR4(+) stem progenitor cells to the bone marrow and spleen on NOD/SCID/B2m(null)mice. Blood 97(10):2383–2391 Li D, Zhao L, Liu M, Du X, Ding W, Zhang J, Mehta JL (1999) Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction. Am Heart J 137:1145–1152 Lu L, Zhang JQ, Ramires FJ, Sun Y (2004) Molecular and cellular events at the site of myocardial infarction: from the perspective of rebuilding myocardial tissue. Biochem Biophys Res Commun 320(3):907–913 Min JY, Yang Y, Converso KL, Liu L, Huang Q, Morgan JP, Xiao YF (2002) Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol 92:288–296 Min JY, Yang Y, Sullivan MF, Ke Q, Converso KL, Chen Y, Morgan JP, Xiao YF (2003) Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg 125:361–369 Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB (2004) Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351(25):2599–2610 Penn MS, Zhang M, Deglurkar I, Topol EJ (2004) Role of stem cell homing in myocardial regeneration. Int J Cardiol 95(suppl 1):S23–S25 Smart SJ, Casale TB (1994) TNF-alpha-induced transendothelial neutrophil migration is IL-8 dependent. Am J Physiol 266:L238–L245 Srour EF, Jetmore A, Wolber FM, Plett PA, Abonour R, Yoder MC, Orschell-Traycoff CM (2001) Homing cell cycle kinetics and fate of transplanted hematopoietic stem cells. Leukemia 15(11):681–684 Szilvassy SJ, Bass MJ, Van Zant G, Grimes B (1999) Organ-selective homing defines engraftment kinetics of murine hematopoietic stem cells and is compromised by ex vivo expansion. Blood 93(5):1557–1566 Tang YL, Qian K, Zhang YC, Shen L, Phillips MI (2005) Mobilizing of haematopoietic stem cells to ischemic myocardium by plasmid-mediated stromal-cell-derived factor-1alpha treatment. Regul Pept 125(1–3):1–8 Tentolouris C, Tousoulis D, Antoniades C, Bosinakou E, Kotsopoulou M, Trikas A, Toutouzas P, Stefanadis C (2004) Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy. Int J Cardiol 94(2–3):301–305 Wang JF, Yang Y, Wang G, Min J, Sullivan MF, Ping P, Xiao YF, Morgan JP (2002) Embryonic stem cells attenuate viral myocarditis in murine model. Cell Transplant 11:753–758 Wang Z, Castresana MR, Newman WH (2001) NF-kapaB is required to TNF-alpha-directed smooth muscle cell migration. FEBS Lett 508:360–364 Widele G, Dunon D, Imhof BA (2001) Current concepts in lymphocyte homing and recirculation. Crit Rev Clin Lab Sci 38(1):1–31 Wynne J, Braunwald E (1997) The cardiomyopathies and mycarditides. In: Braunwald E (ed) Heart disease. W. B. Saunders, Philadelphia, pp 1404–1463 Yang Y, Min JY, Rana JS, Ke Q, Cai J, Chen Y, Morgan JP, Xiao YF (2002) VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells. J Appl Physiol 93(3):1140–1151